The US Food and Drug Administration has authorised the first prescription molecular diagnostic test for Covid-19, which can be performed entirely at home. The FDA issued an Emergency Use Authorisation (EUA) to Lucira Health, Inc...
Full ArticleCovid 19 coronavirus: First home-test kit with rapid results approved
New Zealand Herald
0 shares
4 views
You might like
Related news coverage
NA Proactive news snapshot: Milestone Scientific, Loncor Resources, LeanLife, Genprex, BioSig Technologies UPDATE...
Proactive Investors
Milestone Scientific Inc (NYSEAMERICAN:MLSS) president Arjan Haverhals said Monday that the developer of computerized drug delivery..
-
NA Proactive news snapshot: Western Magnesium, Aequus Pharmaceuticals, Algernon Pharmaceuticals, Hannan Metals, Empower Clinics UPDATE...
Proactive Investors
-
NA Proactive news snapshot: Algernon Pharmaceuticals, Hannan Metals, Empower Clinics, Lingo Media ...
Proactive Investors
-
Source: Pa. lawmaker gets a positive test at Trump meeting
SeattlePI.com
-
NA Proactive news snapshot: Co-Diagnostics, PyroGenesis, Gatling Exploration, GoviEx Uranium, KWESST Micro Systems, Clean Seed Capital UPDATE ...
Proactive Investors
Advertisement
More coverage
How To Protect Healthcare Workers From COVID-19
Eurasia Review
The rapid spread of COVID-19 overwhelmed hospitals that were unable to contend with the increasing number of patients, many..
-
NA Proactive news snapshot: GoviEx Uranium, KWESST Micro Systems, Clean Seed Capital, Killi UPDATE ...
Proactive Investors
-
NA Proactive news snapshot: Vox Royalty, DGTL Holdings, AgraFlora Organics, PreveCeutical Medical UPDATE ....
Proactive Investors
-
Los Angeles to discuss stay-home order as COVID cases rise
SeattlePI.com
-
Coronavirus surge has LA on the brink of a stay-home order
SeattlePI.com